Evolent Health shares are trading lower after Truist Securities downgraded the stock from Buy to Hold rating and maintained the price target
Evolent Health shares are trading lower after Truist Securities downgraded the stock from Buy to Hold rating and maintained the price target at $7.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.